| OMADACYCLINE TOSYLATE | None | ||
| 150MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| NUZYRA is a tetracycline class antibacterial indicated for the treatment of adult patients with the following infections caused by susceptible microorganisms: • Community-acquired bacterial pneumonia (CABP) • Acute bacterial skin and skin structure infections (ABSSSI). | |||
|
Yes
| |||
| NUZYRA | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||
| ***** *** ********** ** *-(*,*-**************-***********) *********** | *********** ********* *** ******* ** *** ******* | **** *** ********** ************ ** ************ ********* | *********** ********* *** ******* ** *** ******* | *-*********** *********** ********* *** **** ******* | *********** ********* *** ******* ** *** ******* | *-*********** *********** ********* *** *** ******* ** ******** *********-******** ********* ********* (****) | *-*********** *********** ********* *** *** ******* ** ******** *********-******** ********* ********* (****) | *-*********** *********** *********** ********* | *****-****** *********** ************ ********* | *-*********** *********** *********** ********* |
| OMADACYCLINE TOSYLATE | None | ||
| 100MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| NUZYRA is a tetracycline class antibacterial indicated for the treatment of adult patients with the following infections caused by susceptible microorganisms: • Community-acquired bacterial pneumonia (CABP) • Acute bacterial skin and skin structure infections (ABSSSI). | |||
|
Yes
| |||
| NUZYRA | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 |
|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||
| *********** ********* *** ******* ** *** ******* | *********** ********* *** ******* ** *** ******* | *********** ********* *** ******* ** *** ******* | *-*********** *********** ********* *** *** ******* ** ******** *********-******** ********* ********* (****) | *-*********** *********** ********* *** *** ******* ** ******** *********-******** ********* ********* (****) | *-*********** *********** *********** ********* | *****-****** *********** ************ ********* | *-*********** *********** *********** ********* |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|